These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1392162)

  • 21. [Treatment of myeloma and and expected prognostic progress].
    Fermand JP
    Rev Prat; 1991 Dec; 41(25):2588-91. PubMed ID: 1687086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.
    Barlogie B; Kyle RA; Anderson KC; Greipp PR; Lazarus HM; Hurd DD; McCoy J; Moore DF; Dakhil SR; Lanier KS; Chapman RA; Cromer JN; Salmon SE; Durie B; Crowley JC
    J Clin Oncol; 2006 Feb; 24(6):929-36. PubMed ID: 16432076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High-dose chemotherapy and bone marrow graft in multiple myeloma: hopes and limits].
    Ravaud P; Fermand JP
    Rev Rhum Ed Fr; 1993 Apr; 60(4):266-8. PubMed ID: 8167622
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of multiple myeloma and its complications].
    Avvisati G; Pulsoni A; Petrucci MT; Tribalto M
    Recenti Prog Med; 1990 Oct; 81(10):642-50. PubMed ID: 2291008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation.
    Hájek R; Adam Z; Vásová I; Král Z
    Acta Med Austriaca; 1996; 23(3):85-91. PubMed ID: 8798281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up after high-dose therapy for high-risk multiple myeloma.
    Barlogie B; Jagannath S; Naucke S; Mattox S; Bracy D; Crowley J; Tricot G; Alexanian R
    Bone Marrow Transplant; 1998 Jun; 21(11):1101-7. PubMed ID: 9645572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
    Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA
    Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biology and therapy of multiple myeloma in 1996.
    Barlogie B; Jagannath S; Epstein J; Munshi N; Siegel D; Desikan KR; Feinman R; Hsu PL; von Bremen K; Tricot G
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):67-72. PubMed ID: 9122748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New protocols for myeloma chemotherapy plus IFN alpha].
    Kitani T
    Rinsho Ketsueki; 1993 Apr; 34(4):455-9. PubMed ID: 8510333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiple myeloma. Biological, prognostic, and therapeutic aspects].
    Corrado C; Pavlovsky S
    Sangre (Barc); 1990 Aug; 35(4):289-97. PubMed ID: 1703328
    [No Abstract]   [Full Text] [Related]  

  • 33. [The role of interferon-alpha in the treatment of multiple myeloma].
    Koyama S
    Nihon Rinsho; 1995 Mar; 53(3):658-63. PubMed ID: 7699901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
    McElwain TJ; Gore ME; Meldrum M; Viner C; Judson IR; Malpas JS
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():109-12. PubMed ID: 2697419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current results of chemotherapy in multiple myeloma].
    Sezaki T
    Gan To Kagaku Ryoho; 1989 May; 16(5):1997-2003. PubMed ID: 2658839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent therapy for refractory myeloma].
    Togawa A
    Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hematopoietic stem cell transplantation in multiple myeloma].
    Vela-Ojeda J; Ruiz-Esparza MA
    Rev Invest Clin; 2005; 57(2):305-13. PubMed ID: 16524072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current therapy concepts in patients with multiple myeloma].
    Heyll A; Schneider P; Bauser U; Kobbe G; Hünerlitürkoglu A; Aul C; Haas R
    Dtsch Med Wochenschr; 2000 Oct; 125(40):1201-9. PubMed ID: 11075253
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatments of multiple myeloma in 1992].
    Monconduit M
    Rev Med Interne; 1992; 13(4):315-8. PubMed ID: 1363152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New aspects in the clinical course determination and therapy in multiple myeloma].
    Ludwig H; Pietschmann H
    Acta Med Austriaca; 1979; 6(5):255-60. PubMed ID: 555224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.